한글목차

5가 백신 시장 규모는 최근 꾸준히 성장하고 있습니다. 2025년 27억 달러에서 2026년에는 28억 3,000만 달러에 이르고, CAGR 4.6%의 성장이 전망됩니다. 지난 몇 년간의 성장 요인으로는 영아 사망률 증가, 백신 접근성 제한, 로타바이러스 감염증의 확산, 정부 주도의 예방접종 정책, 세계 공중보건 캠페인 등을 꼽을 수 있습니다.

5가 백신 시장 규모는 향후 몇 년간, 꾸준한 성장이 전망됩니다. 2030년에는 33억 9,000만 달러에 이르고, CAGR은 4.7%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 백신 제제의 기술 발전, 헬스케어 관련 지출 증가, 개발도상국의 예방접종 프로그램 확대, 제약사 간 제휴, 백신 접종률의 디지털 추적 시스템 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 영유아 예방접종 프로그램 증가, 백신 개발에 대한 정부 자금 지원, 공중보건 인프라 확충, 로타바이러스 예방에 대한 인식 제고, 콜드체인 물류의 성장 등을 들 수 있습니다.

디프테리아의 발병률 증가는 5가 백신 시장 성장을 가속할 것으로 예측됩니다. 디프테리아는 코리네박테리움 디프테리아에 의해 발생하는 심각하고 전염성이 강한 질병으로 호흡곤란, 연하곤란, 피부궤양 등을 유발할 수 있습니다. 5가 백신은 3회의 접종 스케줄을 통해 디프테리아를 포함한 4가지 질병으로부터 어린이를 보호합니다. 그 결과, 디프테리아 발병률 증가에 따라 5가 백신에 대한 수요가 증가하고 있습니다. 예를 들어, 유럽질병예방통제센터(유럽 정부기관)에 따르면, 2025년 7월 기준 독일에서 C. diphtheriae ST574의 확진 사례가 126건 보고되었습니다. 이는 2022년 55건, 2023년 49건, 2024년 18건, 2025년 최소 4건에 비해 눈에 띄게 증가한 수치입니다. 따라서 디프테리아의 유병률 증가가 5가 백신 시장을 주도하고 있습니다.

의료비 지출 증가도 5가 백신 시장 성장을 뒷받침할 것으로 예측됩니다. 헬스케어 지출은 백신 개발, 생산, 유통, 투여를 포함하여 특정 기간 동안 헬스케어 서비스에 대한 총 자금 및 자원 투자를 의미합니다. 지출 증가는 5가 백신을 포함한 백신의 가용성과 보급을 촉진합니다. 예를 들어, 미국 정부 기관인 메디케어-메디케이드 서비스 센터(CMS)에 따르면, 2024년 12월 기준 2023년 미국의 의료비 지출은 7.5% 증가하여 4조 9,000억 달러(1인당 약 1만 4,570달러)에 달할 것으로 예상했습니다. 따라서 의료비 지출 증가는 5가 백신 시장의 확대를 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pentavalent vaccines are designed to protect children from life-threatening diseases. They are used to prevent rotavirus infections in infants and young children, which can cause fever, vomiting, and diarrhea. Administered as part of routine immunization programs, these vaccines provide broad, early protection against major infectious diseases in children.

The main types of pentavalent vaccines include sodium stibogluconate and meglumine antimoniate. Lyophilization, a process that removes water, is often used to preserve perishable products, extend shelf life, or facilitate transportation. The vaccines are available in various formulations, including lyophilized and liquid forms, and are used across hospitals, retail pharmacies, and online pharmacies.

Tariffs have posed challenges for the pentavalent vaccine market by increasing the cost of imported raw materials and vaccine components, thereby affecting production efficiency. Regions like Asia-Pacific and Europe, which are major suppliers of vaccine ingredients, have been most impacted, particularly in hospital and retail pharmacy segments. While tariffs may temporarily increase costs, they also encourage local manufacturing initiatives and supply chain diversification, potentially boosting domestic production and reducing long-term dependency on imports.

The pentavalent market research report is one of a series of new reports from The Business Research Company that provides pentavalent market statistics, including pentavalent industry global market size, regional shares, competitors with a pentavalent market share, detailed pentavalent market segments, market trends and opportunities, and any further data you may need to thrive in the pentavalent industry. This pentavalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pentavalent market size has grown steadily in recent years. It will grow from $2.7 billion in 2025 to $2.83 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to rising infant mortality rates, limited access to vaccines, prevalence of rotavirus infections, government vaccination initiatives, global public health campaigns.

The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to technological advancements in vaccine formulation, increasing healthcare expenditure, expansion of immunization programs in developing countries, partnerships between pharma companies, integration of digital tracking for vaccine coverage. Major trends in the forecast period include increased infant immunization programs, government funding for vaccine development, expansion of public health infrastructure, rising awareness of rotavirus prevention, growth of cold chain logistics.

The rising prevalence of diphtheria is expected to drive growth in the pentavalent vaccine market. Diphtheria, caused by the bacterium Corynebacterium diphtheriae, is a severe and highly contagious disease that can lead to breathing and swallowing difficulties, as well as skin ulcers. Pentavalent vaccines protect children against diphtheria along with four other diseases through a three-dose immunization schedule. Consequently, the increasing prevalence of diphtheria has heightened demand for pentavalent vaccines. For instance, in July 2025, according to the European Centre for Disease Prevention and Control, a Europe-based government agency, Germany reported 126 laboratory-confirmed cases of C. diphtheriae ST574, compared with 55 cases in 2022, 49 in 2023, 18 in 2024, and at least 4 cases in 2025. Therefore, the rising prevalence of diphtheria is propelling the pentavalent vaccine market.

Rising healthcare expenditure is also expected to support growth in the pentavalent market. Healthcare expenditure encompasses the total financial and resource investments made in healthcare services over a specific period, including vaccine development, production, distribution, and administration. Increased spending enhances accessibility and adoption of vaccines, including pentavalent formulations. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per capita. Therefore, rising healthcare expenditure is driving the expansion of the pentavalent vaccine market.

Key companies in the pentavalent market are focusing on the development of advanced combination vaccines that provide protection against multiple diseases. Pentavalent vaccines are designed to immunize individuals against five distinct diseases in a single formulation. For example, in October 2023, Pfizer, a US-based pharmaceutical company, announced FDA approval for its pentavalent vaccine, Penbraya. This is the first and only pentavalent vaccine providing protection against the five most prevalent meningococcal serogroups-A, B, C, W-135, and Y-for individuals aged 10 to 25 years. The vaccine combines elements from the Trumenba meningococcal group B vaccine and the Nimenrix conjugate vaccine for serogroups A, C, W-135, and Y. Penbraya has demonstrated effectiveness in preventing the majority of invasive meningococcal disease cases globally.

Major companies operating in the pentavalent market are Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Asia-Pacific was the largest region in the pentavalent market in 2025. The regions covered in the pentavalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pentavalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pentavalent market consists of sales of pentavalent vaccines such as those for diphtheria, pertussis, tetanus, hepatitis B, and Hib that treat a child against potentially fatal diseases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pentavalent Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pentavalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pentavalent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pentavalent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Pentavalent Vaccines (DTP-HepB-Hib combination); Other Combination Vaccines
• 2) By Formulation Type: Lyophilized; Liquid
• 3) By Application: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Pentavalent Vaccines (DTP-HepB-Hib combination): DTP-HepB-Hib (Whole Cell); DTP-HepB-Hib (Acellular)
• 2) By Other Combination Vaccines: Hexavalent Vaccines
• Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Sanofi SA; GlaxoSmithKline plc; Shandong Xinhua Pharmaceutical Company Limited; PT Bio Farma (Persero); Shantha Biotechnics Limited; Biological E. Limited; Serum Institute of India Private Limited; Indian Immunologicals Limited; Incepta Pharmaceuticals Limited; Shanghai Institute of Biological Products Co Ltd.; Changchun Changsheng Biotechnology Co Ltd.; Adimmune Corporation; AJ Vaccines; Albert David Limited; PanGen Biotech Inc.; Bharat Biotech International Limited; Vacsera Ltd.; Pasteur Institute of India; Zydus Cadila Healthcare Limited; EuBiologics Co Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pentavalent Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pentavalent Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pentavalent Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pentavalent Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Sustainability, Climate Tech & Circular Economy
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increased Infant Immunization Programs
  • 4.2.2 Government Funding For Vaccine Development
  • 4.2.3 Expansion Of Public Health Infrastructure
  • 4.2.4 Rising Awareness Of Rotavirus Prevention
  • 4.2.5 Growth Of Cold Chain Logistics

5. Pentavalent Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Retail Pharmacies
• 5.3 Online Pharmacies
• 5.4 Government Health Departments
• 5.5 Clinics

6. Pentavalent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pentavalent Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pentavalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pentavalent Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pentavalent Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pentavalent Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pentavalent Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pentavalent Market Segmentation

• 9.1. Global Pentavalent Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pentavalent Vaccines (DTP-HepB-Hib combination), Other Combination Vaccines
• 9.2. Global Pentavalent Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lyophilized, Liquid
• 9.3. Global Pentavalent Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.4. Global Pentavalent Market, Sub-Segmentation Of Pentavalent Vaccines (DTP-HepB-Hib combination), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• DTP-HepB-Hib (Whole Cell), DTP-HepB-Hib (Acellular)
• 9.5. Global Pentavalent Market, Sub-Segmentation Of Other Combination Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hexavalent Vaccines

10. Pentavalent Market Regional And Country Analysis

• 10.1. Global Pentavalent Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pentavalent Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pentavalent Market

• 11.1. Asia-Pacific Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pentavalent Market

• 12.1. China Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pentavalent Market

• 13.1. India Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pentavalent Market

• 14.1. Japan Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pentavalent Market

• 15.1. Australia Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pentavalent Market

• 16.1. Indonesia Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pentavalent Market

• 17.1. South Korea Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pentavalent Market

• 18.1. Taiwan Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pentavalent Market

• 19.1. South East Asia Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pentavalent Market

• 20.1. Western Europe Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pentavalent Market

• 21.1. UK Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pentavalent Market

• 22.1. Germany Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pentavalent Market

• 23.1. France Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pentavalent Market

• 24.1. Italy Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pentavalent Market

• 25.1. Spain Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pentavalent Market

• 26.1. Eastern Europe Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pentavalent Market

• 27.1. Russia Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pentavalent Market

• 28.1. North America Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pentavalent Market

• 29.1. USA Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pentavalent Market

• 30.1. Canada Pentavalent Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pentavalent Market

• 31.1. South America Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pentavalent Market

• 32.1. Brazil Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pentavalent Market

• 33.1. Middle East Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pentavalent Market

• 34.1. Africa Pentavalent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pentavalent Market, Segmentation By Type, Segmentation By Formulation Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pentavalent Market Regulatory and Investment Landscape

36. Pentavalent Market Competitive Landscape And Company Profiles

• 36.1. Pentavalent Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pentavalent Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pentavalent Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Shandong Xinhua Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

37. Pentavalent Market Other Major And Innovative Companies

• PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India

38. Global Pentavalent Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pentavalent Market

40. Pentavalent Market High Potential Countries, Segments and Strategies

• 40.1 Pentavalent Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pentavalent Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pentavalent Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer